GlassScriptPhysician profile
Blake R Lambourne
NPI 1194793802
$3,063.87
in general payments reported to CMS, 2019-2025
35 companies · $230 in 2025
The $230 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $335 · 2020: $125 · 2021: $181 · 2022: $356 · 2023: $937 · 2024: $899 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,881 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,880.97 |
| Education | $184.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $607.85 | 2020-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $503.70 | 2019-2024 | |
| Coopersurgical, INC. | $218.70 | 2021-2024 | Endosee |
| Sumitomo Pharma America, INC. | $175.11 | 2023-2025 | Myfembree |
| Daiichi Sankyo INC. | $138.89 | 2019-2024 | Injectafer |
| Mayne Pharma Commercial LLC | $130.37 | 2022-2023 | |
| Pfizer INC. | $126.79 | 2020-2025 | |
| Caldera Medical, INC | $110.76 | 2024 | Desara |
| Sage Therapeutics, LLC | $106.75 | 2024-2025 | Zurzuvae |
| Therapeuticsmd, INC. | $100.43 | 2019-2022 | |
| Organon LLC | $68.85 | 2023-2024 | Nexplanon |
| Neuronetics, INC. | $65.00 | 2022 | |
| Merck Sharp & Dohme LLC | $62.32 | 2019-2023 | Gardasil 9 |
| Millicent US INC | $61.51 | 2024-2025 | Femring, Intrarosa |
| Dysis Medical, INC. | $54.83 | 2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $45.64 | 2023-2025 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $43.21 | 2019-2025 | Coolseal Generator |
| Becton, Dickinson and Company | $41.22 | 2024 | Bd Onclarity |
| Medtronic, INC. | $39.98 | 2021-2023 | Truclear |
| Aspira Women'S Health INC | $37.65 | 2022-2023 | Ova1 |
| Roche Diagnostics Corporation | $36.79 | 2019 | |
| Agile Therapeutics, INC. | $34.12 | 2024 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $33.92 | 2019-2024 | |
| Amag Pharmaceuticals, INC. | $30.84 | 2019 | |
| Meditrina | $30.61 | 2023-2024 | |
| Evofem Biosciences, INC. | $21.19 | 2023 | Phexxi |
| Ethicon US, LLC | $21.09 | 2025 | Stratafix |
| Solta Medical, A Division of Bausch Health US, LLC | $16.70 | 2024 | |
| Convatec INC. | $15.81 | 2023 | |
| Visby Medical, INC. | $15.68 | 2022 | |
| Lilly USA, LLC | $15.38 | 2024 | Zepbound |
| Axonics, INC. | $14.51 | 2022 | |
| Inspire Medical Systems, INC. | $13.56 | 2023 | Inspire |
| Allergan, INC. | $12.41 | 2019 | |
| Vertical Pharmaceuticals, LLC | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blake Lambourne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.